Browse > Article
http://dx.doi.org/10.12749/RDB.2014.38.3.99

Inhibition of mIGF-1 and mGHR Gene Expression using Tetracycline-Inducible RNAi System in Mouse Liver Cell  

Son, Hye Jin (Department of Physiology, Catholic University of Daegu School of Medicine)
Koo, Bon Chul (Department of Physiology, Catholic University of Daegu School of Medicine)
Kwon, Mo Sun (Department of Physiology, Catholic University of Daegu School of Medicine)
Lee, Young Man (Department of Physiology, Catholic University of Daegu School of Medicine)
Kim, Teoan (Department of Physiology, Catholic University of Daegu School of Medicine)
Publication Information
Abstract
In this study, to further understand the mechanism of animal growth and to develop a miniature transgenic animal model, we constructed and tested tetracycline-inducible RNAi system using shRNA targeting the mRNA of mouse insulin-like growth factor (mIGF-1) or mouse growth hormone receptor (mGHR) gene. Quantitative real-time PCR analysis of mouse liver cell (Hepa1c1c7) cells transfected with these vectors showed 85% or 90% of expression inhibition effect of IGF-1 or GHR, respectively. In ELISA analysis, the protein level of IGF-1 in the cells expressing the shRNA targeting IGF-1 mRNA was reduced to 26% of non-transformed control cells. Unexpectedly, in case of using shRNA targeting GHR, the IGF-1 protein level was decreased to 75% of control cells. Further experiments are needed to explain the lower interference effect of GHR shRNA in IGF-1 protein. Accumulated knowledge of this approach could be applicable to a variety of related biological area including gene function study, gene therapy, development of miniature animals, etc.
Keywords
RNAi system; IGF-1; GHR; Albumin promoter; Tetracycline inducible gene expression;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chen YC, Song C, Luo CQ (2003): Short hairpin RNAs induced RNA interference in human cells. Ai Zheng 22:566-570.
2 Cunningham SM, Cunningham MD, Zhu L, Kain S (1997): Determination and correlation of expression levels of luciferase and EGFP using the tetracycline-controlled gene expression system and fluorescence imaging. Neuroscience Abs 23:647.
3 Devroe E, Silver PA (2002): Retrovirus-delivered si-RNA. BMC Biotechnol 2:15.   DOI
4 Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001): Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.   DOI   ScienceOn
5 Eshet R, Laron Z, Pertzelan A, Arnon R, Dintzman M (1984): Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr J Med Sci 20:8-11.
6 Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998): Potent and specific genetic interference by double-stranded RNA in Caenorhababditis elegans. Nature 391:806-811.   DOI   ScienceOn
7 Freundlieb S, Schirra-Muller C, Bujard H (1999): A tetracycline controlled activation/repression system for mammalian cells. J Gene Med 1:4-12.   DOI   ScienceOn
8 Gupta S, Schoer RA, Egan JE, Hannon GJ, Mittal V (2004): Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci 101:1927-32.   DOI   ScienceOn
9 Isaksson OG, Lindahl A, Nilsson A, Isgaard J (1987): Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8:426-438.   DOI   ScienceOn
10 Kwak YD, Koike H, Sugaya K (2003): RNA Interference with small hairpin RNAs transcribed from a human U6 promoter-driven DNA vector. J Pharmacol Sci 93:214-217.   DOI
11 Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993): Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72.
12 Livak KJ, Schmittgen TD (2001): Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods 25: 402-408.   DOI   ScienceOn
13 Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A (2001): Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-162.   DOI   ScienceOn
14 Tai CK, Kasahara N (2008): Replication-competent retrovirus vectors for cancer therapy. Front Biosci 13:3083-3095.   DOI
15 Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W (2000): Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 97:7963-7968.   DOI   ScienceOn
16 Van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, Holstege FC, Brummelkamp TR, Agami R, Clevers H (2003): Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4:609-615.   DOI   ScienceOn
17 Zhu Z, Ma B, Homer RJ, Zheng T, Elias JA (2001): Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J Biol Chem 276:25222-25229.   DOI   ScienceOn
18 Wilson JA, Richardson CD (2003): Induction of RNA interference using short interfering RNA expression vectors in cell culture and animal systems. Curr Opin Mol Ther 5:389-396.
19 Witzgall R, O'Leary E, Leaf A, Onaldi D, Bonventre JV (1994): The Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. Proc Natl Acad Sci 91:4514-4518.   DOI
20 Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G, Kopchick JJ (1997): A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:13215-20.   DOI   ScienceOn
21 Zhu Z, Zheng T, Lee CG, Homer RJ, Elias JA (2002): Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling. Semin Cell Dev Biol 13:121-128.   DOI   ScienceOn